Log In
BCIQ
Print this Print this
 

DKN-01

  Manage Alerts
Collapse Summary General Information
Company Leap Therapeutics Inc.
DescriptionHumanized IgG4 mAb against dickkopf homolog 1 (DKK1)
Molecular Target Dickkopf homolog 1 (DKK1)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/29/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today